Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MMM | Common Stock | Options Exercise | $242K | +1.9K | +43.28% | $127.22 | 6.29K | Nov 1, 2024 | Direct | F1 |
transaction | MMM | Common Stock | Tax liability | -$110K | -866 | -13.77% | $127.22 | 5.42K | Nov 1, 2024 | Direct | |
holding | MMM | Common Stock | 555 | Nov 1, 2024 | By 401k/paesop Trust |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MMM | Restricted Stock Units | Options Exercise | $0 | -1.9K | -100% | $0.00 | 0 | Nov 1, 2024 | Common Stock | 1.9K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | The shares originally reported were adjusted due to the spin-off of Solventum, the Company's healthcare business group, on April 1, 2024. |
F2 | Each restricted stock unit represents a contingent right to receive one share of 3M common stock. |
F3 | The restricted stock units vest in three years from the grant date. |